미시간의 궤양성 대장염 임상 시험
궤양성 대장염 관련 연구 17개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.
미시간의 도시
공식 연구 텍스트(영어)
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07415044LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinical Research Institute of Michigan, LLC, Clinton Township
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Huron Gastroenterology Associates, P.C., Ypsilanti
피험자 모집 중4상
18세 ~ 65세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07185009A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06581328Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
- University of Michigan, Ann Arbor
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Michigan Center of Medical Research, Farmington Hills
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07184996A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06100289A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT06598943Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT07456566A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- William Beaumont Hospital/Corewell Health - East, Royal Oak
- William Beaumont Hospitals Reference Laboratory, Royal Oak
피험자 모집 중2상
12세 ~ 17세 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400012, Wyoming
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.